Official Journal of Research Center for Gastroenterology and Liver Diseases
CrossRef
Works that cite this article, indexed by Crossref.
Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review
PharmacoEconomics - Open 4(3) (2020)
Peter Wigfield; Urbano Sbarigia; Mahmoud Hashim; Talitha Vincken; Bart Heeg
Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve
Iranian Journal of Pharmaceutical Research 23(1) (2024)
Homa Hemati; Marzieh Nosrati; Mandana Hasanzad; Parham Rahmani; Soroush Fariman; Mohadese Sarabi; Sepideh Shirvani; Parham Sadeghipour; Shekoufeh Nikfar
A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North Africa
Applied Health Economics and Health Policy 20(3) (2022)
Mouaddh Abdulmalik Nagi; Pramitha Esha Nirmala Dewi; Montarat Thavorncharoensap; Sermsiri Sangroongruangsri
Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
BMC Health Services Research 22(1) (2022)
Mehdi Rezaee; Mohammad Hossein Morowvat; Maryam Poursadeghfard; Armin Radgoudarzi; Khosro Keshavarz
Cost‐Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
BioMed Research International 2021(1) (2021)
Ahmad Gholami; Jassem Azizpoor; Elham Aflaki; Mehdi Rezaee; Khosro Keshavarz; Mihajlo Jakovljevic
A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran
Cost Effectiveness and Resource Allocation 23(1) (2025)
Mojtaba Jafari; Parisa Mehdizadeh; Khosro Keshavarz; Ehsan Teymourzadeh; Mohammad Ali Abyazi; Seyed Moayed Alavian; Alijanpour Pouria
QALY league table of Iran: a practical method for better resource allocation
Cost Effectiveness and Resource Allocation 19(1) (2021)
Reza Hashempour; Behzad Raei; Majid Safaei Lari; Nasrin Abolhasanbeigi Gallezan; Ali AkbariSari
Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies
Applied Health Economics and Health Policy 23(4) (2025)
Zainab Abdali; Tuba Saygın Avşar; Sue Jowett; Muslim Syed; Khalifa Elmusharaf; Louise Jackson
Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study
BMJ Open 15(9) (2025)
Mojtaba Jafari; Parisa Mehdizadeh; Khosro Keshavarz; Ehsan Teymourzadeh; Mohammad Ali Abyazi; Parsa Gholamreza Shirazi
Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective
Value in Health Regional Issues 42 (2024)
Mehdi Rezaee; Iman Karimzadeh; Amir Hashemi-Meshkini; Shahryar Zeighami; Mohammad Bazyar; Farhad Lotfi; Khosro Keshavarz
Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C
Hepatitis Monthly 21(8) (2021)
Zahra Goudarzi; Abdollah Poursamad; Iman Karimzadeh; Nahid Jallaly; Khosro Keshavarz; Seyed Moayed Alavian
Cost-utility analysis of Edaravone compared to Riluzole in patients with amyotrophic lateral sclerosis (ALS) in Iran
Cost Effectiveness and Resource Allocation 24(1) (2026)
Habib Omranikhoo; Mehdi Rezaee; Ali Verdizadeh; Zahra Goudarzi; Mojtaba Jafari; Ahmad Gholami; Maryam Poursadeghfard; Khosro Keshavarz
Cost‐Effectiveness of Dimethyl Fumarate Versus Teriflunomide in Patients With Relapsing‐Remitting Multiple Sclerosis (RRMS) in Iran
Health Science Reports 9(4) (2026)
Maryam Poursadeghfard; Yasin Farjah; Mehdi Rezaee; Nastaran Momtahan; Mohammad Hossein Morowvat; Ahmad Gholami; Khosro Keshavarz